| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 3 |
| 1 | OXALIPLATIN | 3 |
| 2 | PANTOPRAZOLE | 3 |
| 3 | PANTOPRAZOLE SODIUM | 3 |
| 4 | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | 3 |
| 5 | PANTOPRAZOLE SODIUM INJECTION | 3 |
| 6 | ATENOLOL | 2 |
| 7 | BEVACIZUMAB-ADCD | 2 |
| 8 | CYCLOPHOSPHAMIDE | 2 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-ADCD | 2 | 0.0099 |
| 1 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 2 | 0.0002 |
| 2 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| 3 | TELMISARTAN | 2 | 0.0001 |
| 4 | ENCORAFENIB | 1 | 0.0001 |
| 5 | VINCRISTINE SULFATE | 2 | 0.0001 |
| 6 | PANTOPRAZOLE SODIUM INJECTION | 3 | 0.0000 |
| 7 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 8 | OXALIPLATIN | 3 | 0.0000 |
| 9 | CAPECITABINE | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 1 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Factor Xa Inhibitor [EPC] | 2 | 0.0000 |
| 8 | beta-Adrenergic Blocker [EPC] | 2 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2 | 0.0000 |